JPS62138411A - Cosmetic for preventing skin from ageing - Google Patents

Cosmetic for preventing skin from ageing

Info

Publication number
JPS62138411A
JPS62138411A JP60280397A JP28039785A JPS62138411A JP S62138411 A JPS62138411 A JP S62138411A JP 60280397 A JP60280397 A JP 60280397A JP 28039785 A JP28039785 A JP 28039785A JP S62138411 A JPS62138411 A JP S62138411A
Authority
JP
Japan
Prior art keywords
skin
cosmetic
effect
extract
blood circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60280397A
Other languages
Japanese (ja)
Inventor
Tatsu Miyamoto
達 宮本
Kenji Mori
憲治 森
Toshiyuki Motoi
元井 利幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP60280397A priority Critical patent/JPS62138411A/en
Publication of JPS62138411A publication Critical patent/JPS62138411A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Abstract

PURPOSE:The titled cosmetic that contains, as active ingredients, gamma- linolenic acid, as a major ingredient, essence of Swertia japonica, ginseng essence, vitamin E orotate, placerta extract and other blood circulation promoter and/or cell-activator. CONSTITUTION:The titled cosmetic contains (A) 0.05-3wt% of gamma-linolenic acid and (B) ingredients having actions to promote blood circulation and/or to activate cells. As an ingedient B, at least one selected from essence of Swertia japonica, ginseng essence, vitamin D orotate, diisopropylamine dichloroacetate, gamma-aminobutyric acid, D-pantothenyl ether, D- pantothenylethyl alcohol, and placenta extract is cited. The ingredient B is combined with ingredient A, which is an essential fatty acid with high physiological activity to activate the skin function to prevent skins from wrinkling and simultaneously keep skins moist and of fine texture. Thus, the cosmetic can develop synergistically aging-prevention action in a short time and keep the action continuously.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、主成分であるγ−リルン酸と、血行促進作用
及び/または細胞賦活作用を有する成分とを含有するこ
とを特徴とする皮膚老化防止用化粧料に関する。更に詳
しくは皮膚老化防止効果(荒れ肌改善効果、角質数倍効
果、角質層のターンオーバー速度を速くする効果、シワ
の減少等)の優れた皮膚老化防止用化粧料に関する。
Detailed Description of the Invention (Industrial Application Field) The present invention is directed to a method for treating skin characterized by containing γ-lylunic acid as a main component and a component having a blood circulation promoting effect and/or a cell activating effect. Regarding anti-aging cosmetics. More specifically, the present invention relates to cosmetics for preventing skin aging that have excellent skin aging prevention effects (improving rough skin, several times more stratum corneum effect, increasing the turnover rate of the stratum corneum, reducing wrinkles, etc.).

(従来の技術) 老化した皮膚は柔軟性、弾力性を失い、皮膚のシワが増
大し、乾燥して滑かさのない荒れ肌で、角質細胞剥離現
象が認められる。
(Prior Art) Aging skin loses its flexibility and elasticity, wrinkles increase, the skin becomes dry and rough without smoothness, and a phenomenon of exfoliation of keratin cells is observed.

リノール酸、α−リルン酸を始めとする必須脂肪酸は、
人体内で生合成が行なわれず、外部から食事により摂取
する必要がある。この必須脂肪酸が欠乏した場合、皮膚
の落屑化、発育不全等を生じ、著しく皮膚の老化を促進
することか知られている。
Essential fatty acids, including linoleic acid and α-lylunic acid, are
It is not biosynthesized within the human body and must be ingested from the outside through food. It is known that a deficiency of this essential fatty acid causes skin desquamation, stunted growth, etc., and significantly accelerates skin aging.

(発明が解決しようとする問題点) 本発明者らは、上記の問題に艦み、老化皮膚を組織学的
、形態学的、生化学的或は生理学的に長年鋭怠検討した
結果、皮屑化粧料の基剤の中に、必須脂肪酸の中でも最
も生理活性か高いr −’Jノレン酸と、後記特定の物
質との両者を併用する場合は、両者による相乗効果によ
って優れた皮膚老化防止効果(荒れ肌改善効果、角質改
善効果に優れ、結合組織のコラーゲン/エラスチン比ヲ
低くしてしわを少なくすると同時にターンオーバー速度
を速くする効果)が使用開始後1ケ月というごく短時間
に発現する速効性で、かつ持続性のある皮膚老化防止用
化粧料が得られることを見出し、−本発明を完成した。
(Problems to be Solved by the Invention) In view of the above-mentioned problems, the inventors of the present invention have carefully investigated aging skin histologically, morphologically, biochemically, and physiologically for many years. When r-'J-nolenic acid, which has the highest physiological activity among essential fatty acids, and a specific substance described below are used together in the base of a scrap cosmetic, the synergistic effect of both will result in excellent skin aging prevention. A fast-acting product that shows its effects (excellent for improving rough skin and keratin, lowering the collagen/elastin ratio of connective tissue to reduce wrinkles and speed up turnover rate) within a very short time of one month after starting use. The present invention has been completed by discovering that it is possible to obtain a cosmetic composition for preventing skin aging that is both effective and long-lasting.

(問題点を解決しようとする手段) 即ち、本発明はγ−リルン酸と、血行促進作用および/
または細胞賦活作用を有する成分とを含有す2.ことを
特徴とする皮膚老化防止用化粧料に関するものである。
(Means for Solving the Problems) That is, the present invention provides γ-lylunic acid, blood circulation promoting action and/or
or a component having a cell activating effect; 2. The present invention relates to a cosmetic for preventing skin aging characterized by the following.

本発明にいう血行促進作用および/または細胞V、活佳
作用有する成分とは、センブリエキス、朝鮮ニンジンエ
キス、ビタミンEオロテート、ジイソプロピルアミンジ
クロロアセテート、γ−アミノ酪酸、D−パントテニル
エチルエーテル、D−パントテニルエチルアルコール、
胎盤抽出物からなる群から選択された少なくとも一極が
特に好ましいが、その他アロエ抽出物、ビタミンEニコ
チネート、ビオチン等も適用される。
In the present invention, the ingredients having a blood circulation promoting effect and/or a cell V, activating effect include Jasmine japonica extract, Korean ginseng extract, vitamin E orotate, diisopropylamine dichloroacetate, γ-aminobutyric acid, D-pantothenyl ethyl ether, D - pantothenyl ethyl alcohol,
Particularly preferred is at least one selected from the group consisting of placenta extract, but other substances such as aloe extract, vitamin E nicotinate, biotin, etc. are also applicable.

本発明に使用する、r−リルン酸は、モルティエ5属(
特開昭57−144986)、ムコール属(Lipid
s、6. 584. 1971)を始めとする微生物の
細胞膜、また月見草オイル、1し乳等に得意的に存在す
ることが知られている必須脂肪酸の一極であり、通常の
脂質抽出法、加水分解法により得られる。
The r-lylunic acid used in the present invention is of the Mortier genus 5 (
JP 57-144986), Mucor genus (Lipid
s, 6. 584. It is one of the essential fatty acids that is known to be present in the cell membranes of microorganisms such as (1971), as well as in evening primrose oil, milk, etc., and can be obtained by conventional lipid extraction methods and hydrolysis methods. .

前記特定の血行促進剤あるいは細胞賦活剤のうち、天然
物の抽出物であるセンブリエキス、朝鮮ニンジンエキス
の製造法に門しては特定されるものではないが、各々の
製造法の概要は下記の通りである。
Among the above-mentioned specific blood circulation promoters or cell activators, there are no specific manufacturing methods for the natural product extracts such as Oriental japonica extract and Korean ginseng extract, but the outline of each manufacturing method is as follows. It is as follows.

〔センブリエキスの製造法〕[Production method of Aspergillus japonica extract]

センブリ(5wertia JapOniCa Mak
ino)の韻花期全草の乾燥粉砕物をエタノール或いは
含水エタノール中で温浸し、ろ別して得られた抽出液で
ある。実施例には、下記の方法で得られた抽出液を利用
した。
Assembly (5wertia JapOniCa Mak
This is an extract obtained by digesting the dried and pulverized whole plant of Ino) in flowering stage in ethanol or aqueous ethanol and filtering it. In the Examples, an extract obtained by the following method was used.

センブリ細砕物50yを含水エタノール(エタノール9
Qwt%)250g/に温度40〜50°Cで温浸して
ろ別した後、再び残渣を同様に温浸することを数回くり
返し、抽出液1.51を得た。これを減圧濃縮した残留
物に精製水を100g/加え、1週間熟成した後、不溶
部をろ別して得た抽出液を減圧濃縮し、次いでエタノー
ルを加えて抽出液のエタノール含有量が4Qwt %に
なるように調整し、10(1+/のセンブリエキスを得
た。
50 y of crushed Aspergillus japonica was mixed with water-containing ethanol (ethanol 9
Qwt%) 250g/digested at a temperature of 40 to 50°C, filtered, and digested again in the same manner as the residue several times to obtain 1.51 of an extract. After concentrating this under reduced pressure, 100 g of purified water was added to the residue, and after aging for 1 week, the insoluble portion was filtered off and the obtained extract was concentrated under reduced pressure. Then, ethanol was added to the extract until the ethanol content of the extract was 4 Qwt%. 10 (1+/) of Aspergillus japonica extract was obtained.

〔朝鮮ニンジンエキスの製造法〕[Production method of Korean carrot extract]

オタネニンジン(Panax ginseng C,A
、 Meyer)の5〜6年根乾燥細砕物をエタノール
或いは含水エタノール中に冷浸し、ろ別して得られた抽
出液である。実施例には下記の方法でえられた抽出液を
利用した。
Panax ginseng (Panax ginseng C, A
This is an extract obtained by cold-soaking 5- to 6-year-old dried and crushed roots of A., Meyer) in ethanol or aqueous ethanol, and filtering the mixture. In the Examples, an extract obtained by the following method was used.

オタネニンジン細砕物50ノを含水エタノール(エタノ
ール9Qwt%) 200 mlに1週間冷浸し、ろ別
して得られた抽出液のエタノールを留去し、精製水を加
えて抽出液のエタノール含有量が5Qwt%になるよう
に調整し、更にこれを7〜10週間冷所で熟成した後、
ろ別して100 mlの朝鮮ニンジンエキスを得た。
Fifty pieces of crushed Panax ginseng were cold soaked in 200 ml of aqueous ethanol (ethanol 9Qwt%) for one week, filtered, and the ethanol obtained from the extract was distilled off, and purified water was added to bring the ethanol content of the extract to 5Qwt%. After adjusting it so that it becomes
It was filtered to obtain 100 ml of Korean ginseng extract.

r−リルン酸の化粧料への配合量は、特に限定されず広
範囲に選択することができるが、組成物の全量重量に対
して通常0.01〜10重1%、好ましくは0.05〜
8重量%である。
The amount of r-lylunic acid to be added to cosmetics is not particularly limited and can be selected from a wide range, but it is usually 0.01 to 10% by weight, preferably 0.05 to 1% by weight, based on the total weight of the composition.
It is 8% by weight.

前記の血行促進剤及び/または細胞賦活剤を本発明の化
粧料に配合する量は、その作用効果あるいは当該化粧料
の剤型等により適宜調整されるものであるが通常後記の
第1表に示す配合量が好適である。なお配合量は化粧料
組成物の全量重量を基準とした。
The amount of the blood circulation promoter and/or cell activator to be blended into the cosmetic of the present invention is appropriately adjusted depending on its effect or the dosage form of the cosmetic, but it is usually as shown in Table 1 below. The amounts shown are suitable. The blending amount was based on the total weight of the cosmetic composition.

1.4′)−/′ 第    1   表 本発明の皮膚老化防止用化粧料は、r−’)ルン酸と、
前記の血行促進剤あるいは細胞賦活剤とを、クリーム、
乳液、ローシ目ン等の皮膚化粧料基剤の中に直接添加す
るか、またはそれらの化合物を油相成分、水相成分、ア
ルコール等の溶剤に溶解して配合し、乳化、混合、分散
、溶解、可溶化等の処理を行なうことによって調製され
る。
1.4')-/' Table 1 The cosmetic composition for preventing skin aging of the present invention comprises r-') phosphoric acid,
The above blood circulation promoter or cell activator is combined with cream,
It can be added directly to skin cosmetic bases such as emulsions and lotions, or it can be blended by dissolving these compounds in oil phase components, aqueous phase components, and solvents such as alcohol to emulsify, mix, disperse, and It is prepared by performing treatments such as dissolution and solubilization.

(発明の効果) 本発明の皮膚老化防止用化粧料は、皮膚機能を冗進し、
肌のしわを防止し、肌理(きめ)こまかなかつしっとり
とした皮膚にすると共に、優れた皮膚老化防止効果(荒
れ肌改善効果、角質改善効果に優れ、ターンオーバー速
度を早める効果)を、相乗的にかつ短時間に発現し、持
続する等、顕著な効果を奏し得る。
(Effect of the invention) The cosmetic for preventing skin aging of the present invention enhances skin functions,
It synergistically prevents skin wrinkles, makes the skin smooth and moisturized, and has an excellent anti-aging effect (improves rough skin, improves dead skin cells, and speeds up skin turnover). Moreover, it can produce remarkable effects, such as appearing in a short period of time and lasting for a long time.

(実施例) 以下、実施例について説明する。(Example) Examples will be described below.

なあ、実施例に示す%とは重量%を意味する。Note that % shown in Examples means % by weight.

実施例に記載の角質層のターンオーバー速度測定方法、
荒れ肌改善効果の測定試験法、角質改善効果の測定試験
法は゛下記の通りである。
Method for measuring turnover rate of stratum corneum described in Examples,
The test method for measuring the effect of improving rough skin and the test method for measuring the effect of improving keratin are as follows.

(1)角質層のターンオーバー速度測定方法蛍光色素の
ダンジルクロライドを白色ワセリン中に5重置%配合し
た軟膏を作り、被検者の前腕部の皮膚に24時間閉塞貼
布し、角質層にダンジルクロライドを浸透結合させる。
(1) Method for measuring the turnover rate of the stratum corneum. An ointment containing 5% of the fluorescent dye danzyl chloride in white petrolatum is made, and the ointment is applied to the skin of the subject's forearm for 24 hours, and then the stratum corneum is danzyl chloride is osmotic-bonded to.

その後同じ部位に1日2回(朝・夕)被検試料を塗布し
、毎日ダンジルクロライドの蛍光をしらべ、その蛍光が
消滅するまでの日数を皮膚角質層のターンオーバー速度
とした。なお、通常の皮膚角質層のターンオーバー速度
は14〜16日であるが、老化した皮膚においては18
日前後にのびる。それに対して老化防止効果が現れると
12日前後にまで短縮される。
Thereafter, the test sample was applied to the same area twice a day (morning and evening), and the fluorescence of danzyl chloride was examined every day.The number of days until the fluorescence disappeared was defined as the turnover rate of the skin stratum corneum. Note that the turnover rate of the normal skin stratum corneum is 14 to 16 days, but in aged skin it is 18 days.
It grows around the day. On the other hand, if the anti-aging effect appears, the time will be shortened to around 12 days.

(2)荒れ肌改善効果の測定試験法 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。被験者の左側下脚試験部
位に1日2回約1gの化粧料試料を塗布し、試験開始前
および終了後の皮膚の状態を第2表の茫準により判定し
た。右側下脚は試料を塗布せず対照とした。
(2) Test method for measuring the effect of improving rough skin The effect of continuous application for 4 weeks was investigated on 20 middle-aged and elderly subjects who had rough skin on their lower legs. Approximately 1 g of the cosmetic sample was applied to the test site of the test subject's left lower leg twice a day, and the condition of the skin before and after the start of the test was evaluated according to the scale shown in Table 2. No sample was applied to the right lower leg, which served as a control.

第2表 皮膚乾燥度の判定基準 −:正常 ±  :1徹乾燥、落屑なし +  :乾燥、落屑軽度 ++:乾煽、落屑中等度 +十+:乾燥、落屑顕著 試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば+→−1
++→±)を「有効」、1段階改善された場合を「やや
有効」、変化がなかった場合を「無効」とした。尚、試
験期間中に皮膚の乾燥が進んだ例はなかった。
Table 2 Judgment criteria for skin dryness -: Normal ±: 1 Thorough dryness, no scaling +: Dryness, mild scaling ++: Excessive dryness, moderate scaling + 10+: Dryness, significant scaling Test site and control site before and after the test Compare the judgment results and if the skin dryness has improved by two or more levels (for example, + → -1
++→±) was considered "effective," one level of improvement was considered "slightly effective," and no change was considered "ineffective." There were no cases of skin dryness progressing during the test period.

(3)角質改善(角質細胞の抗剥離性増大)効果の測定
試験法 前述の荒れ肌改善測定試験開始前および終了後の被験部
皮膚にスコッチテープにチバンメンディングテープ)を
接着し、これを剥離した時テープに付着した角質細胞の
状態を走査型電子顕微鏡によって詳細に調べ、第3表の
基準によって皮膚角質細胞抗剥離′性を分離し、角質改
善効果を求めた0 第3表 角質細胞の剥m特性判定If5準第3表は4週
間連続塗布後の試験部位の評価点と対照部位のそれとの
差が2点以上の場合を「有効」、1点の場合を「やや有
効」、0点の場合を「無効」とした。
(3) Test method for measuring the effect of improving keratin (increasing the anti-peeling properties of keratinocytes) Apply Scotch tape (Tiban Mending Tape) to the test area skin before and after the above-mentioned rough skin improvement measurement test, and peel it off. The condition of the corneocytes attached to the tape was examined in detail using a scanning electron microscope, and the skin corneocyte anti-exfoliation property was separated according to the criteria in Table 3, and the corneum improvement effect was determined. Peeling characteristic evaluation If5 semi-Table 3 shows that if the difference between the evaluation score of the test site and that of the control site after 4 weeks of continuous application is 2 or more points, it is "effective", if it is 1 point, it is "slightly effective", and 0. Points were considered "invalid".

なお、この角質細胞の剥離特性は、角質層の構造特性を
判断する指標となるものであって、一般に乾燥皮膚、老
化皮膚に於ては、細胞間結合風が弱く、また、その構造
の緻密性も低いことから指数が高くなることが確認され
ている。
The exfoliation properties of these corneocytes serve as an index for determining the structural properties of the stratum corneum, and in general, in dry skin and aging skin, the intercellular bonds are weak and the structure is dense. It has been confirmed that the index is high due to the low gender.

(4)官能効果のパネルテスト 30名の中年(80〜50才)女子パネラ−の顔面に試
料を1日2回、4ケ月間連続塗布し、パネラ一本人が1
ケ月後および終了後の皮膚の状態を、「シわ伸ばし効果
」、「きめに対する効果」、「しっとり感に対する効果
」につきそれぞれ評価した。
(4) Sensory effect panel test Samples were applied to the faces of 30 middle-aged (80-50 years old) female panelists twice a day for 4 months, and each panelist applied 1
The condition of the skin after one month and the end of the treatment was evaluated for ``wrinkle smoothing effect,'' ``effect on texture,'' and ``effect on moisturizing feeling.''

(ν人工1色・白) 実施例1(スキンミルク) 第   4   表 上記第4表に示す処方の各スキンミルクを常法により調
製した。得られた実施例1および比較例8の各スキンク
リームの皮膚老化防止効果(荒れ肌改善効果、角質改善
効果、角質層のターンオーバー速度)の拭動結果につい
ては第5表に比較例1および比較例2の皮膚老化防止効
果の試験結果については第6表に示した。
(ν Artificial color, white) Example 1 (Skin milk) Table 4 Each skin milk having the formulation shown in Table 4 above was prepared by a conventional method. Table 5 shows the results of wiping the skin anti-aging effects (improving effect on rough skin, improving effect on dead skin cells, turnover rate of stratum corneum) of each skin cream of Example 1 and Comparative Example 8. The test results for the anti-aging effect on the skin of Example 2 are shown in Table 6.

第5表:r−リルン酸を配合したスキンミルクの皮膚老
化防止効果 ※やや有効は含まない。以下の表中の記載も同じ。
Table 5: Skin aging prevention effect of skin milk containing r-lylunic acid *Slightly effective does not include. The same applies to the descriptions in the table below.

第6表:γ−リルン酸を配合しないスキンミルクの皮膚
老化防止効果 上記の結果から明らかなように r  IJルン酸と前
記の血行促進剤あるいは細胞賦活剤とを併用配合した本
発明のスキンミルク(実施例1−1〜実施例1−8)で
は皮膚老化防止効果(荒れ肌改善効果、角賀改善効果寥
よひ角質層のターンオーバー速度を速くする効果)が、
相乗的に向上し、発現している。
Table 6: Skin anti-aging effect of skin milk without γ-phosphoric acid As is clear from the above results, the skin milk of the present invention containing r IJ phosphoric acid and the above-mentioned blood circulation promoter or cell activator. In (Example 1-1 to Example 1-8), the skin aging prevention effect (the effect of improving rough skin, the effect of improving Kadoha, and the effect of increasing the turnover rate of the stratum corneum),
It is synergistically improved and expressed.

これに対して、r  !Jルン酸のみを配合した比較例
3のスキンミルクおよび前記の血行促進剤あるいは細胞
賦活剤のみを配合した比較例2のスキンミルク(比較例
2−1〜比較例2−8)では、皮膚老化防止効果が低い
。そして、γ−リルン酸と、前記の血行促進剤あるいは
細胞賦活剤の両者を含有(併用)しない比較例1のスキ
ンミルク(スキンミルクベース)では皮膚老化防止効果
は認められ、ない。
On the other hand, r! The skin milk of Comparative Example 3 containing only J-phosphoric acid and the skin milk of Comparative Example 2 containing only the blood circulation promoter or cell activator (Comparative Examples 2-1 to 2-8) have no effect on skin aging. Prevention effect is low. In addition, the skin milk (skin milk base) of Comparative Example 1 that does not contain (combined) both γ-lylunic acid and the above-mentioned blood circulation promoter or cell activator has no skin aging prevention effect.

次に実用テストの結果について示す。Next, we will show the results of practical tests.

(以下゛余゛白) 第7表:γ−リルン酸を配合したスキンミルクの実用テ
ストの結果 (1ケ月後) 第8表:、IJルン酸を配合したスキンミルクの実用テ
ストの結果 (4ケ月後) 第9表:r−リルン酸を配合しないスキンミルクの実用
テストの結果 (1ケ月後) 第10表:r−リルン酸を配合しないスキンミルクの実
用テストの結果 (4ケ月後) 上記の結果からも明らかなように、r−リルン酩と前記
の血行促進剤あるいは細胞賦活剤とを併用配合した本発
明のスキンミルク(実施例1−1〜実施例1−8)では
、しわをのばす効果、きめに対する効果、しっとり感に
対する効果のいずれもが、使用し始めて1ケ月後から現
われて、速効性が顕著で、かつ持続性を了fし、しかも
諸効果が著しく優れている。
(Hereinafter referred to as "Extras") Table 7: Results of a practical test of skin milk containing γ-lylunic acid (after 1 month) Table 8: Results of a practical test of skin milk containing IJ phosphoric acid (4 Table 9: Practical test results of skin milk without r-lylunic acid (after 1 month) Table 10: Practical test results of skin milk without r-lylunic acid (after 4 months) Above As is clear from the results, the skin milk of the present invention (Examples 1-1 to 1-8) containing r-Rirun alcohol and the above-mentioned blood circulation promoter or cell activator can reduce wrinkles. The spreading effect, the effect on texture, and the effect on moisturizing sensation all appear after one month of use, and the effect is remarkable, fast-acting, and long-lasting, and the various effects are outstanding.

これに対して、γ−リルン酸のみを配合した比較例8お
よび前記の血行促進剤あるいは細胞賦活剤のみを配合し
た比較例2(比較例2−1〜比較例2−8)のスキンミ
ルクではいずれの効果においても比較的低くかつ遅効性
である。なお、対照品としてのスキンミルクベース(基
剤)では、前記の効果が認められなかった。
In contrast, the skin milks of Comparative Example 8 containing only γ-lylunic acid and Comparative Example 2 (Comparative Examples 2-1 to 2-8) containing only the blood circulation promoter or cell activator mentioned above Both effects are relatively low and slow-acting. In addition, the above-mentioned effect was not observed in skin milk base (base) as a control product.

II  □+’(+II □+’(+

Claims (2)

【特許請求の範囲】[Claims] (1)γ−リノレン酸と、血行促進作用及び/または細
胞賦活作用を有する成分とを含有することを特徴とする
皮膚老化防止用化粧料。
(1) A cosmetic for preventing skin aging, characterized by containing γ-linolenic acid and a component having a blood circulation promoting effect and/or a cell activating effect.
(2)血行促進作用及び/または細胞賦活作用を有する
成分が、センブリエキス、朝鮮ニンジンエキス、ビタミ
ンEオロテート、ジイソプロピルアミンジクロロアセテ
ート、γ−アミノ酪酸、D−パントテニルエチルエーテ
ル、D−パントテニルエチルアルコール、胎盤抽出物か
らなる群から選択された少なくとも一種である特許請求
の範囲第(1)項に記載の皮膚老化防止用化粧料。
(2) Ingredients that have a blood circulation promoting effect and/or a cell activating effect include Jasmine japonica extract, Korean ginseng extract, vitamin E orotate, diisopropylamine dichloroacetate, γ-aminobutyric acid, D-pantothenylethyl ether, D-pantothenylethyl The cosmetic for preventing skin aging according to claim (1), which is at least one selected from the group consisting of alcohol and placenta extract.
JP60280397A 1985-12-12 1985-12-12 Cosmetic for preventing skin from ageing Pending JPS62138411A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60280397A JPS62138411A (en) 1985-12-12 1985-12-12 Cosmetic for preventing skin from ageing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60280397A JPS62138411A (en) 1985-12-12 1985-12-12 Cosmetic for preventing skin from ageing

Publications (1)

Publication Number Publication Date
JPS62138411A true JPS62138411A (en) 1987-06-22

Family

ID=17624457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60280397A Pending JPS62138411A (en) 1985-12-12 1985-12-12 Cosmetic for preventing skin from ageing

Country Status (1)

Country Link
JP (1) JPS62138411A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0615753A1 (en) * 1993-03-19 1994-09-21 Scotia Holdings Plc Formulation for use in smokers
JPH09268118A (en) * 1996-04-01 1997-10-14 Kao Corp Skin color-improving beautifier
FR2765482A1 (en) * 1997-07-07 1999-01-08 Oreal USE OF Y-LINOLENIC ACID TO PREVENT OXIDATIVE STRESS
JP2002080370A (en) * 2000-09-04 2002-03-19 Kose Corp Antiaging agent and cosmetic containing the same
KR100361433B1 (en) * 1998-05-28 2003-01-24 주식회사 태평양 Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng
CN104758227A (en) * 2015-03-19 2015-07-08 卢家雄 Peach blossom essential oil eye cream
JP2018528248A (en) * 2015-09-24 2018-09-27 イーエルシー マネージメント エルエルシー Methods and compositions for treating skin

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0615753A1 (en) * 1993-03-19 1994-09-21 Scotia Holdings Plc Formulation for use in smokers
US5562913A (en) * 1993-03-19 1996-10-08 Scotia Holdings Plc Formulation for use in smokers
JPH09268118A (en) * 1996-04-01 1997-10-14 Kao Corp Skin color-improving beautifier
FR2765482A1 (en) * 1997-07-07 1999-01-08 Oreal USE OF Y-LINOLENIC ACID TO PREVENT OXIDATIVE STRESS
EP0891773A1 (en) * 1997-07-07 1999-01-20 L'oreal Use of gamma-linolenic acid for preventing oxydative stress
JPH1171260A (en) * 1997-07-07 1999-03-16 L'oreal Sa Oxidation stress preventing agent comprising gamma-linolenic acid
KR100361433B1 (en) * 1998-05-28 2003-01-24 주식회사 태평양 Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng
JP2002080370A (en) * 2000-09-04 2002-03-19 Kose Corp Antiaging agent and cosmetic containing the same
JP4723064B2 (en) * 2000-09-04 2011-07-13 株式会社コーセー Anti-aging agent and cosmetics containing the same
CN104758227A (en) * 2015-03-19 2015-07-08 卢家雄 Peach blossom essential oil eye cream
JP2018528248A (en) * 2015-09-24 2018-09-27 イーエルシー マネージメント エルエルシー Methods and compositions for treating skin

Similar Documents

Publication Publication Date Title
JPH07196469A (en) Cosmetics composition for care of composite skin
JP2002020225A (en) Humectant composition
CN110974767A (en) Composition for skin barrier regeneration repair and application thereof
KR20210105880A (en) Novel cosmetic and dermatological uses of Cistus monspeliensis extract
EP2393557A2 (en) Composition for treatment of skin
JP3908126B2 (en) Epidermal keratinization normalizing agent and skin external preparation containing the same
US4569931A (en) Sebum secretion accelerator
JP3922311B2 (en) Skin aging prevention cosmetics
JPS6220165B2 (en)
JPS6219511A (en) Cosmetic for preventing aging of skin
JPS62138411A (en) Cosmetic for preventing skin from ageing
JP3193542B2 (en) Anti-aging skin cosmetics
JPH1135455A (en) Collagen production promoter and skin lotion for preventing aging of skin or promoting healing of wound containing the same promoter
JPS63150209A (en) Skin cosmetic
JPH0733637A (en) Skin cosmetic
JP3507635B2 (en) Composition suitable for external use
JP3170700B2 (en) Cosmetic for preventing skin aging
JPS6281307A (en) Skin cosmetic
JPH09315930A (en) Cosmetic material for skin
JPS62148414A (en) Skin cosmetic
RU2384322C2 (en) Day gel cream for dry and normal skin
JPH04334308A (en) Skin cosmetic
JPS62249907A (en) Cosmetic
JPH09255546A (en) Skin preparation for external use
JP3277033B2 (en) Cosmetics